Monte Rosa Therapeutics
Developing next-generation small molecule protein degraders to treat cancer and beyond.
HQ location
Boston, United States
Founding location
Basel, Switzerland
Website
Launch date
Employees
Market cap
$298m
Enterprise value
$49m
Share price
$4.83 GLUE
Company register number
CHE-405.675.696
Authorizing premium user...